SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-06-05 11:16
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Valliant, John Fitzmaurice
5 - Senior Officer of Issuer
Holder: Centre for Probe Development and Commercialization in trust for Valliant Consulting & Management Inc. (Indirect Ownership)
Voting Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
-318,147 vol 		0
Filed 2024-06-05 11:15
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Valliant, John Fitzmaurice
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Units
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
-192,200 vol 		0
Filed 2024-06-05 11:15
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Valliant, John Fitzmaurice
5 - Senior Officer of Issuer
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
-1,139,816 vol 		0
Filed 2024-06-05 11:14
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Valliant, John Fitzmaurice
5 - Senior Officer of Issuer
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
-443,828 vol 		0
Filed 2024-06-05 11:14
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Valliant, John Fitzmaurice
5 - Senior Officer of Issuer
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
-2,142,489 vol 		0
Filed 2024-03-12 15:36
Tx date 2022-02-01 		$FUSN
Fusion Pharmaceuticals Inc. 		Valliant, John Fitzmaurice
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+406,600 vol 		1,322,089
Filed 2024-01-05 11:57
Tx date 2024-01-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Valliant, John Fitzmaurice
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Units
56 - Grant of rights
+192,200 vol 		192,200
Filed 2024-01-05 11:56
Tx date 2020-06-25 		$FUSN
Fusion Pharmaceuticals Inc. 		Valliant, John Fitzmaurice
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
Filed 2024-01-05 11:56
Tx date 2024-01-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Valliant, John Fitzmaurice
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+320,400 vol 		1,735,889
Filed 2024-01-05 11:53
Tx date 2024-01-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Valliant, John Fitzmaurice
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+320,400 vol
Filed 2024-01-05 11:52
Tx date 2024-01-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Valliant, John Fitzmaurice
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+320,400 vol
Filed 2023-01-09 09:12
Tx date 2023-01-05 		$FUSN
Fusion Pharmaceuticals Inc. 		Valliant, John Fitzmaurice
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+500,000 vol 		1,415,489
Filed 2023-01-09 09:12
Tx date 2023-01-05 		$FUSN
Fusion Pharmaceuticals Inc. 		Valliant, John Fitzmaurice
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+500,000 vol
Filed 2023-01-09 09:11
Tx date 2023-01-05 		$FUSN
Fusion Pharmaceuticals Inc. 		Valliant, John Fitzmaurice
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+500,000 vol
Filed 2022-04-29 09:14
Tx date 2022-04-27 		$FUSN
Fusion Pharmaceuticals Inc. 		Valliant, John Fitzmaurice
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Centre for Probe Development and Commercialization in trust for Valliant Consulting & Management Inc. (Indirect Ownership)
Voting Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$-27,201.33
-4,511 vol
$6.03 each 		318,147
Filed 2022-04-26 16:45
Tx date 2022-04-26 		$FUSN
Fusion Pharmaceuticals Inc. 		Valliant, John Fitzmaurice
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Centre for Probe Development and Commercialization in trust for Valliant Consulting & Management Inc. (Indirect Ownership)
Voting Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$-13,032.29
-2,147 vol
$6.07 each 		322,658
Filed 2022-04-26 16:44
Tx date 2022-04-25 		$FUSN
Fusion Pharmaceuticals Inc. 		Valliant, John Fitzmaurice
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Centre for Probe Development and Commercialization in trust for Valliant Consulting & Management Inc. (Indirect Ownership)
Voting Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$-12,277.08
-2,036 vol
$6.03 each 		324,805
Filed 2022-04-21 17:00
Tx date 2022-04-21 		$FUSN
Fusion Pharmaceuticals Inc. 		Valliant, John Fitzmaurice
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Centre for Probe Development and Commercialization in trust for Valliant Consulting & Management Inc. (Indirect Ownership)
Voting Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$-5,541.22
-922 vol
$6.01 each 		326,841
Filed 2022-04-21 08:18
Tx date 2022-04-20 		$FUSN
Fusion Pharmaceuticals Inc. 		Valliant, John Fitzmaurice
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Centre for Probe Development and Commercialization in trust for Valliant Consulting & Management Inc. (Indirect Ownership)
Voting Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$-2,209.34
-367 vol
$6.02 each 		327,763
Filed 2022-04-18 16:00
Tx date 2022-04-13 		$FUSN
Fusion Pharmaceuticals Inc. 		Valliant, John Fitzmaurice
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Centre for Probe Development and Commercialization in trust for Valliant Consulting & Management Inc. (Indirect Ownership)
Voting Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$-76,881.54
-11,994 vol
$6.41 each 		328,130